Switching from OpenLoop or Bask? Free white-glove migration in days.
PharmaBro
  1. Home
  2. Blog
  3. Operator guide
Operator guide

Telehealth intake: screen before you charge

Where the eligibility rules run decides whether an ineligible patient is a polite decline or a refund, a processing fee and a dispute. It is the most expensive ordering decision in the funnel.

Priya RaghunathanHead of Compliance Operations4 min read

Key takeaways

  • Run eligibility inside the form, before payment. Screening after checkout converts declines into refunds and disputes.
  • Condition-specific intake beats one generic form reskinned per category, clinically and commercially.
  • State drives the pathway, including whether an initial prescription needs a synchronous visit.
  • Retain the exact intake version the patient saw, so an audit is a lookup rather than a reconstruction.
  • A complete structured history means fewer clarification round trips and faster approvals.
01

The ordering decision that costs the most

There are two possible sequences. Screen, then charge. Or charge, then screen.

The second is common because it maximises the number of people who reach checkout, and on a dashboard it looks like better conversion. What it actually produces is a population of patients who paid and were then declined by a provider. Each one is a refund, a lost processing fee, a support interaction, and a dispute risk.

In a category already coded high risk by processors, a chargeback ratio driven by post-payment declines is not merely expensive. It threatens the merchant account itself.

02

Condition-specific, not one form with a dropdown

A generic intake adapted per category asks the wrong questions in the wrong depth. A weight management intake needs BMI, comorbidities, thyroid and pancreatitis history. A sexual health intake needs nitrate use and cardiovascular history. A testosterone intake needs fertility intentions in a way no other category does.

Writing each form for its own therapy improves clinical quality and reduces provider clarification messages, which shortens time to approval and therefore time to first shipment.

03

Put state logic in the form

The patient's state determines which clinician can see them, whether the initial encounter can be asynchronous, and in some categories whether the therapy is available at all.

Encoding that in the intake means the patient is routed correctly without your team knowing the map, and means a rule change is a central update rather than retraining. It also means you decline a patient in an unavailable state before taking their money rather than after.

04

Verify identity and age where the category demands it

Several categories carry statutory or practical age floors, and some carry additional restrictions at the upper end. Sexual health commonly has a floor around 21, with further limitations for much older patients. Scheduled testosterone commonly carries a floor around 25.

Age gates and identity verification belong in the flow rather than in terms and conditions nobody reads. This is also a fraud control: identity verification reduces both clinical risk and payment risk simultaneously.

05

Version everything and keep it

An audit two years from now will ask what a specific patient was asked and what they answered. If your form has changed eleven times since, an unversioned record cannot answer that.

Retaining the exact intake version alongside the provider's decision, the prescription event and the pharmacy transmission turns a compliance question into a lookup. It costs nothing at write time and is close to impossible to reconstruct afterwards.

06

What screening first does to your metrics

The visible effect is that checkout conversion drops, because people who were never eligible no longer reach checkout. That is a better number, not a worse one, and it is worth explaining to whoever watches the dashboard.

The real effects are downstream: approval rate becomes a genuine clinical metric rather than an artefact of who you let through, refunds fall, dispute rates fall, support load falls, and the funnel your ad platform sees is cleaner, which matters when your account is under prescription-category scrutiny.

Where PharmaBro fits

Eligibility rules that run inside the form

PharmaBro's intake builder attaches eligibility rules to specific answers, evaluated live as the patient responds. A disqualifying answer ends the flow with an explanation before a payment method is ever requested.

Forms are condition-specific, state logic is built into the routing, and every version is retained per patient. Rule changes go live the same day without a developer.

Conclusion

Intake is not a form. It is the control point where clinical safety, payment risk and funnel quality all meet.

Screen before you charge, write the form for the therapy rather than adapting one, put state logic in the routing, and keep versioned records. The dashboard number will look slightly worse and the business will be measurably better.

Frequently asked questions

Should eligibility screening run before or after payment?

Before, without exception. Charging a patient a provider will decline creates a refund, a lost processing fee and a dispute risk, and it corrupts every funnel metric you have. It is the most expensive avoidable mistake in telehealth intake design.

How long should a telehealth intake form be?

Long enough for a provider to make a safe decision without messaging the patient for clarification, and no longer. Clarification round trips cost more conversion than the extra questions would have, because they delay approval and shipping.

Do I need a different form for each condition?

Yes. The questions that matter differ genuinely by therapy, and a generic form adapted per category asks the wrong things in the wrong depth. It also produces worse provider decisions and more clarification messages.

Written by

Priya RaghunathanHead of Compliance Operations

Handles LegitScript, HIPAA posture, MSO structuring and state coverage. Writes the parts of this blog that operators wish someone had told them before they signed.